ATI Real Life Clinical Scenarios – Actual ATI Modules Questions Spread Across Detailed Case Studies (Correctly Answered with Rationales)

ATI REAL LIFE CLINICAL SCENARIOS ACTUAL ATI
i i i i i i i



MODULES
QUESTIONS SPREAD ACROSS DETAILED CASE STUDIES
i i i i i i



CORRECTLY
ANSWERED AND RATIONALES PROVIDED i i i




i




Exam Instructions
i i




i Totali Questions:i 75i
• Format:i Thisi exami containsi multiplei casei studiesi representingi ATIi Reali Lifei
scenarios.i Eachi casei studyi includesi ai patienti scenarioi followedi byi questionsi thati
assessi clinicali judgmenti andi decision-making.i Questionsi mayi includei multiplei
choice,i selecti alli thati apply,i orderedi response,i andi matrix/gridi formats.i
• Time:i Takei thisi exami ini ai quieti environment,i allowingi approximatelyi 2-3i hoursi fori
completion.i


i




Case Study 1: Adult Medical-Surgical - Chronic Kidney Disease
i i i i i i i i i




Scenario:i Margareti Chen,i ai 68-year-oldi femalei withi ai 15-yeari historyi ofi typei 2i diabetesi
mellitusi andi hypertension,i isi admittedi toi thei medical-surgicali uniti withi complaintsi ofi
progressivei fatigue,i nausea,i swellingi ini heri loweri extremities,i andi decreasedi urinei outputi
overi thei pasti 2i weeks.i Shei reportsi shei hasi beeni nonadherenti withi heri medicationsi fori thei
pasti monthi duei toi cost.i

Vitali Signs:i HRi 92i bpm,i BPi 168/94i mmHg,i RRi 20/min,i SpO2i 95%i oni roomi air,i
Temperaturei 98.4°Fi (36.9°C).i

,Assessmenti Findings:i

• Cardiovascular:i +2i pittingi edemai bilaterali loweri extremities,i jugulari venousi
distentioni notedi wheni supine.i
• Respiratory:i Lungi soundsi cleari bilaterally.i
• Gastrointestinal:i Reportsi nausea,i noi vomiting.i Appetitei poor.i
• Renal:i Urinei outputi 150i mLi overi thei pasti 8i hours.i
• Skin:i Skini dry,i pruritusi notedi oni backi andi arms.i

Laboratoryi Results:i

• Serumi Creatinine:i 4.8i mg/dLi (High)i
• BUN:i 68i mg/dLi (High)i
• Serumi Potassium:i 5.9i mEq/Li (High)i
• Serumi Phosphorus:i 6.2i mg/dLi (High)i
• eGFR:i 14i mL/min/1.73m²i
• Hemoglobin:i 9.2i g/dLi (Low)i



i




Questioni 1i (Recognizei Cues)i

Thei nursei reviewsi thei admissioni assessmenti data.i Whichi findingsi arei mosti indicativei ofi
worseningi kidneyi function?i (Selecti alli thati apply.)i

*A.i Serumi Creatininei 4.8i mg/dL*i
B.i Urinei outputi 150i mLi overi 8i hoursi
*C.i Bloodi pressurei 168/94i mmHg*i
*D.i +2i pittingi edemai ini loweri extremities*i
E.i Pruritusi oni backi andi armsi
*F.i Hemoglobini 9.2i g/dL*i

,Answeri &i Rationale:i *A,i B,i D.i Serumi creatininei (A)i isi ai directi measurei ofi kidneyi functioni
andi isi significantlyi elevated.i Decreasedi urinei outputi (B)i ofi <30i mL/houri indicatesi oliguriai
andi reducedi glomerulari filtration.i Edemai (D)i resultsi fromi fluidi retentioni duei toi thei
kidneys'i inabilityi toi excretei sodiumi andi water.i Hypertensioni (C)i isi ai commoni findingi buti
noti thei mosti specifici indicatori ofi worseningi function.i Pruritusi (E)i andi anemiai (F)i arei
chronici complicationsi ofi kidneyi diseasei buti doi noti directlyi indicatei acutei worsening.*i


i




Questioni 2i (Analyzei Cues)i

Basedi oni thei laboratoryi findings,i thei nursei identifiesi hyperkalemiai asi ai criticali concern.i
Whichi assessmenti findingsi wouldi thei nursei expecti toi observei ini ai patienti withi severei
hyperkalemia?i

A. Musclei weaknessi andi cardiaci dysrhythmiasi
B. Hyperactivei deepi tendoni reflexesi andi tetanyi
C. Tachypneai andi deepi respirationsi
D. Hypertensioni andi boundingi pulsesi

Answeri &i Rationale:i A.i Hyperkalemiai affectsi thei membranei potentiali ofi cells,i leadingi toi
musclei weaknessi andi life-threateningi cardiaci dysrhythmias,i includingi peakedi Ti waves,i
widenedi QRS,i andi potentiallyi asystole.i Optioni Bi describesi hypocalcemia.i Optioni Ci
describesi compensationi fori metabolici acidosis.i Optioni Di isi noti characteristici ofi
hyperkalemia.i


i




Questioni 3i (Prioritizei Hypotheses)i

Thei provideri prescribesi severali interventions.i Whichi interventioni shouldi thei nursei
implementi FIRST?i

, A.i Administeri sodiumi polystyrenei sulfonatei (Kayexalate)i orallyi
b.i Inserti ani indwellingi urinaryi catheteri
C. Obtaini ani ECGi
D. Starti ai peripherali IVi linei

Answeri &i Rationale:i *C.i Obtainingi ani ECGi isi thei priorityi becausei hyperkalemiai (5.9i
mEq/L)i cani causei life-threateningi cardiaci changesi ati anyi moment.i Thei ECGi providesi
immediatei informationi abouti cardiaci statusi andi guidesi thei urgencyi ofi treatment.i Whilei
alli interventionsi arei important,i assessingi cardiaci statusi takesi precedence.i Kayexalatei (A)i
willi takei timei toi work.i Catheteri insertioni (B)i andi IVi accessi (D)i arei importanti buti
secondaryi toi cardiaci assessment.*i


i




Questioni 4i (Generatei Solutions)i

Thei patient'si ECGi revealsi peakedi Ti waves.i Thei provideri ordersi IVi calciumi gluconate.i
Whati isi thei primaryi purposei ofi administeringi calciumi gluconatei ini thisi situation?i

A. Toi loweri thei serumi potassiumi leveli byi exchangingi iti ini thei GIi tracti
B. Toi stabilizei thei cardiaci membranei andi preventi life-threateningi dysrhythmiasi
C. Toi shifti potassiumi fromi thei bloodstreami intoi thei cellsi
D. Toi bindi withi phosphatei andi loweri phosphorusi levelsi

Answeri &i Rationale:i B.i Calciumi gluconatei doesi noti loweri thei serumi potassiumi level.i
Instead,i iti antagonizesi thei cardiaci effectsi ofi hyperkalemiai byi stabilizingi thei myocardiali
membrane,i protectingi againsti ventriculari fibrillationi andi asystole.i Optioni Ai describesi
sodiumi polystyrenei sulfonate.i Optioni Ci describesi insulini andi albuterol.i Optioni Di describesi
phosphatei binders.i


i